Table 3.
Association between median of one-carbon metabolism related nutrients and disease progression in breast cancer patients stratified by clinicopathological characteristics
|
|
Below median |
Above median |
|
||
---|---|---|---|---|---|---|
No. of total | No. of events | No. of total | No. of events | HR (95%CI)a | ||
|
TNM stage |
|
|
|
|
|
Vitamin B2, mg |
I-II |
350 |
39 |
466 |
58 |
1.40 (0.85-2.30) |
|
III |
68 |
16 |
96 |
28 |
1.13 (0.52-2.43) |
Vitamin B6, mg |
I-II |
362 |
46 |
454 |
51 |
1.02 (0.61-1.73) |
|
III |
74 |
19 |
90 |
25 |
1.05 (0.49-2.27) |
Folate, mg |
I-II |
397 |
48 |
419 |
49 |
1.10 (0.69-1.75) |
|
III |
91 |
21 |
73 |
23 |
1.52 (0.77-3.01) |
|
Lymph-node status |
|
|
|
|
|
Vitamin B2, mg |
Negative |
242 |
25 |
335 |
35 |
1.28 (0.67-2.42) |
|
Positive |
172 |
29 |
218 |
49 |
1.40 (0.81-2.44) |
Vitamin B6, mg |
Negative |
251 |
28 |
326 |
32 |
1.22 (0.63-2.34) |
|
Positive |
181 |
36 |
209 |
42 |
0.88 (0.49-1.56) |
Folate, mg |
Negative |
284 |
30 |
293 |
30 |
1.23 (0.68-2.24) |
|
Positive |
199 |
38 |
191 |
40 |
1.12 (0.67-1.87) |
|
Hormone status |
|
|
|
|
|
Vitamin B2, mg |
ER + and/or PR+ |
300 |
34 |
398 |
40 |
0.91 (0.52-1.59) |
|
ER–/PR– |
111 |
21 |
153 |
43 |
2.28 (1.20-4.35) |
Vitamin B6, mg |
ER + and/or PR+ |
305 |
39 |
393 |
35 |
0.57 (0.32-1.03) |
|
ER–/PR– |
125 |
26 |
139 |
38 |
1.86 (0.97-3.56) |
Folate, mg |
ER + and/or PR+ |
333 |
39 |
365 |
35 |
0.82 (0.49-1.40) |
|
ER–/PR– |
148 |
30 |
116 |
34 |
1.84 (1.02-3.32) |
|
Nuclear grade |
|
|
|
|
|
Vitamin B2, mg |
I-II |
223 |
23 |
302 |
34 |
1.22 (0.64-2.34) |
|
III |
185 |
32 |
241 |
50 |
1.43 (0.82-2.49) |
Vitamin B6, mg |
I-II |
226 |
29 |
299 |
28 |
0.56 (0.28-1.11) |
|
III |
200 |
36 |
226 |
46 |
1.28 (0.73-2.24) |
Folate, mg |
I-II |
250 |
31 |
275 |
26 |
0.69 (0.38-1.27) |
III | 224 | 38 | 202 | 44 | 1.59 (0.95-2.66) |
Abbreviation: ER, estrogen receptor; PR, progesterone receptor.
a Adjusted for age, education, recruited site, TNM stage, hormone status, nuclear grade and total calorie.